Boill Healthcare Holdings Limited (Stock Code: 01246) published a monthly return for the period ended 31 October 2024, submitted on 20 January 2026. According to the announcement, the authorized share capital stood at 480,000,000 ordinary shares with a par value of HKD 0.25 each, amounting to HKD 120,000,000. No changes were recorded in authorized share capital during the month.

The total number of issued ordinary shares remained at 1,358,000,000, with zero shares held in treasury. The public float requirement continued to be met as per the relevant listing rules.

Regarding share option schemes, no new shares were issued or treasury shares transferred during October. A scheme adopted on 27 September 2023 provided for up to 135,800,000 shares to be issued or transferred, but there was no exercise of options, and no funds were raised. No warrants, convertibles, or other arrangements to issue shares were reported. The total number of issued shares and treasury shares remained unchanged throughout the month.